Using the galactomannan antigen assay in the diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 2, 2012, Pages 379-382

  Tǎnase, Alina Daniela ^a   Coliţǎ, Anca ^a   Mǎrculescu, Alexandra ^a   Berteanu, Cristina ^b   Streinu Cercel, A ^c   Stoica, Maria ^d   Stoica, A ^d   Cernea, Daniela ^d   Copotoiu, Sanda ^b   Brînzaniuc, Klara ^b   Azamfirei, L ^b  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c 'Matei Bal ' Institute for Infectious Diseases   (Romania)

^d UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Galactomannan; Hematopoietic stem cell transplant; Invasive aspergillosis

Indexed keywords

EID: 84864987981     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. VandenBergh MF, Verweij PE, Voss A, Epidemiology of nosocomial fungal infections: invasive aspergillosis and the environment, Diagn Microbiol Infect Dis, 1999, 34(3):221-227.
2. Walsh TJ, Chanock SJ, Diagnosis of invasive fungal infections: advances in nonculture systems, Curr Clin Top Infect Dis, 1998, 18:101-153.
3. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, Fanci R, Caramatti C, Invernizzi R, Mattei D, Mitra ME, Melillo L, Aversa F, Van Lint MT, Falcucci P, Valentini CG, Girmenia C, Nosari A, The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study, Haematologica, 2006, 91(8):1068-1075.
4. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C, Lioure B, Bilger K, Lutun P, Marcellin L, Launoy A, Freys G, Bergerat JP, Herbrecht R, Factors associated with overall and attributable mortality in invasive aspergillosis, Clin Infect Dis, 2008, 47(9):1176-1184.
5. Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F, Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne, Clin Infect Dis, 2007, 45(9):1161-1170.
6. Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A, Buelli M, Picardi M, Allione B, Corvatta L, D'Antonio D, Montillo M, Melillo L, Chierichini A, Cenacchi A, Tonso A, Cudillo L, Candoni A, Savignano C, Bonini A, Martino P, Del Favero A; GIMEMA Infection Program; Gruppo Italiano Malattie Ematologiche dell'Adulto, Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program, Haematologica, 2001, 86(8):862-870.
7. Mühlemann K, Wenger C, Zenhäusern R, Täuber MG, Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies, Leukemia, 2005, 19(4):545-550.
8. Nucci M, Spector N, Bueno AP, Solza C, Perecmanis T, Bacha PC, Pulcheri W, Risk factors and attributable mortality associated with superinfections in neutropenic patients with cancer, Clin Infect Dis, 1997, 24(4):575-579.
9. Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A, Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature, Haematologica, 1997, 82(3): 297-304.
10. Marr KA, Carter RA, Crippa F, Wald A, Corey L, Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients, Clin Infect Dis, 2002, 34(7):909-917.
11. Barnes PD, Marr KA, Aspergillosis: spectrum of disease, diagnosis, and treatment, Infect Dis Clin North Am, 2006, 20(3):545-561.
12. Lin SJ, Schranz J, Teutsch SM, Aspergillosis case-fatality rate: systematic review of the literature, Clin Infect Dis, 2001, 32(3):358-366.
13. Mennink-Kersten MA, Donnelly JP, Verweij PE, Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis, Lancet Infect Dis, 2004, 4(6):349-357.
14. Stynen D, Sarfati J, Goris A, Prévost MC, Lesourd M, Kamphuis H, Darras V, Latgé JP, Rat monoclonal antibodies against Aspergillus galactomannan, Infect Immun, 1992, 60(6):2237-2245.
15. th European Congress of Clinical Microbiology and Infectious Diseases, Nice, France, April 1-4, 2006, abstract no.: s277.
16. Hope WW, Walsh TJ, Denning DW, Laboratory diagnosis of invasive aspergillosis, Lancet Infect Dis, 2005, 5(10):609-622.
17. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M, Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation, Blood, 2001, 97(6):1604-1610.
18. Rovira M, Jimenéz M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M, Almela M, Martínez C, Fernández-Avilés F, Martínez JA, Urbano-Ispizua A, Carreras E, Montserrat E, Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study, Transplantation, 2004, 77(8):1260-1264.
19. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases, Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus, Clin Infect Dis, 2002, 34(1):7-14.
20. Wald A, Leisenring W, van Burik JA, Bowden RA, Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation, J Infect Dis, 1997, 175(6):1459-1466.